Literature DB >> 34120606

Exosomal circRNA as a novel potential therapeutic target for multiple myeloma-related myocardial damage.

Runjie Sun1, Wei Liu2, Yangang Zhao3, Haoyu Chen4, Zhenzhen Wang5, Yanyu Zhang1, Xiaoqi Sun1, Xing Cui6.   

Abstract

INTRODUCTION: Myocardial damage is a mostly incurable complication of multiple myeloma (MM) that seriously affects the treatment outcome and quality of life of patients. Exosomal circular RNAs (exo-circRNAs) play an important role in tumor occurrence and development and are considered key factors in MM pathogenesis. However, the role and mechanism of action of exo-circRNAs in MM-related myocardial damage are still unclear. This study aimed to investigate correlations between exo-circRNAs and MM and to preliminarily explore the role of exo-circRNAs in MM-related myocardial damage.
METHODS: Six MM patients and five healthy controls (HCs) were included in the study. High-throughput sequencing and qRT-PCR verification were used to obtain a profile of abnormally expressed exo-circRNAs. GO, KEGG, miRanda, TargetScan and Metascape were used for bioinformatics analyses. H9C2 cells treated with exosomes from U266 cells were used in cell experiments. CCK-8, PCR, immunofluorescence and western blotting assays were used to detect cell proliferation and expression of autophagy-related indicators. Electron microscopy was used to observe the number of autophagic vesicles.
RESULTS: Bioinformatics analysis showed that circRNAs with upregulated expression had the potential to promote MM-related myocardial damage. In addition, PCR results confirmed that circ-G042080 was abundantly expressed in the serum exosomes of 20 MM patients. Correlation analysis showed that the expression level of circ-G042080 was positively correlated with the clinical level of MM and MM-related myocardial damage and that circ-G042080 might interfere with MM-related myocardial damage through a downstream miRNA/TLR4 axis. Cell experiments demonstrated that the circ-G042080/hsa-miR-4268/TLR4 axis might exist in H9C2 cells incubated with exosomes and cause abnormal autophagy.
CONCLUSION: Abnormal expression of serum exo-circRNAs was found to be associated with MM-related myocardial damage, suggesting that exo-circRNAs might become a new diagnostic marker of MM-related myocardial damage and a therapeutic target.

Entities:  

Keywords:  Circular RNA; Exosome; Multiple myeloma; Myocardial damage

Year:  2021        PMID: 34120606     DOI: 10.1186/s12935-021-02011-w

Source DB:  PubMed          Journal:  Cancer Cell Int        ISSN: 1475-2867            Impact factor:   5.722


  62 in total

Review 1.  Functional role of circular RNAs in cancer development and progression.

Authors:  Wei Lun Ng; Taznim Begam Mohd Mohidin; Kirti Shukla
Journal:  RNA Biol       Date:  2018-08-04       Impact factor: 4.652

2.  Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis.

Authors:  Yan Li; Qiupeng Zheng; Chunyang Bao; Shuyi Li; Weijie Guo; Jiang Zhao; Di Chen; Jianren Gu; Xianghuo He; Shenglin Huang
Journal:  Cell Res       Date:  2015-07-03       Impact factor: 25.617

Review 3.  Management of multiple myeloma in the newly diagnosed patient.

Authors:  María-Victoria Mateos; Jesús F San Miguel
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

Review 4.  Gynecologic cancers and non-coding RNAs: Epigenetic regulators with emerging roles.

Authors:  Zahra Sadat Razavi; Vida Tajiknia; Shahab Majidi; Maryam Ghandali; Hamid Reza Mirzaei; Neda Rahimian; Michael R Hamblin; Hamed Mirzaei
Journal:  Crit Rev Oncol Hematol       Date:  2020-12-05       Impact factor: 6.312

5.  Anti-Cancer Activity of Curcumin on Multiple Myeloma.

Authors:  Hamed Mirzaei; Hossein Bagheri; Faezeh Ghasemi; Jaber M Khoi; Mohammad H Pourhanifeh; Yvan V Heyden; Erfan Mortezapour; Ali Nikdast; Philippe Jeandet; Haroon Khan; Amirhossein Sahebkar
Journal:  Anticancer Agents Med Chem       Date:  2020-09-18       Impact factor: 2.505

6.  Circular RNAs are a large class of animal RNAs with regulatory potency.

Authors:  Sebastian Memczak; Marvin Jens; Antigoni Elefsinioti; Francesca Torti; Janna Krueger; Agnieszka Rybak; Luisa Maier; Sebastian D Mackowiak; Lea H Gregersen; Mathias Munschauer; Alexander Loewer; Ulrike Ziebold; Markus Landthaler; Christine Kocks; Ferdinand le Noble; Nikolaus Rajewsky
Journal:  Nature       Date:  2013-02-27       Impact factor: 49.962

Review 7.  Circular RNAs: Promising Biomarkers for Human Diseases.

Authors:  Zhongrong Zhang; Tingting Yang; Junjie Xiao
Journal:  EBioMedicine       Date:  2018-08-02       Impact factor: 8.143

8.  Diagnosis and Management of a Cardiac Amyloidosis Case Mimicking Hypertrophic Cardiomyopathy.

Authors:  Yasar Sattar; Tania Ruiz Maya; Fnu Zafrullah; Nirav B Patel; Sharaad Latchana
Journal:  Cureus       Date:  2018-12-18

Review 9.  Management of cardiovascular risk in patients with multiple myeloma.

Authors:  Chris Plummer; Christoph Driessen; Zsolt Szabo; María-Victoria Mateos
Journal:  Blood Cancer J       Date:  2019-02-26       Impact factor: 11.037

Review 10.  Circular RNAs in cancer: new insights into functions and implications in ovarian cancer.

Authors:  Zahra Shabaninejad; Asma Vafadar; Ahmad Movahedpour; Younes Ghasemi; Afshin Namdar; Hadis Fathizadeh; Mohammad Hossein Pourhanifeh; Amir Savardashtaki; Hamed Mirzaei
Journal:  J Ovarian Res       Date:  2019-09-03       Impact factor: 4.234

View more
  11 in total

Review 1.  CircRNAs: novel therapeutic targets in multiple myeloma.

Authors:  Xinyi Zhou; Juan Du
Journal:  Mol Biol Rep       Date:  2022-06-21       Impact factor: 2.316

Review 2.  Extracellular vesicle-mediated bidirectional communication between heart and other organs.

Authors:  Khatia Gabisonia; Mohsin Khan; Fabio A Recchia
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-02-18       Impact factor: 4.733

Review 3.  Circular RNAs and Their Role in Exosomes.

Authors:  Zeping Han; Huafang Chen; Zhonghui Guo; Jian Shen; Wenfeng Luo; Fangmei Xie; Yu Wan; Shengbo Wang; Jianhao Li; Jinhua He
Journal:  Front Oncol       Date:  2022-04-28       Impact factor: 5.738

Review 4.  The emerging landscape of exosomal CircRNAs in solid cancers and hematological malignancies.

Authors:  Qinfeng Zhou; Dacheng Xie; Rong Wang; Lianfang Liu; Yue Yu; Xinyi Tang; Yongxian Hu; Dawei Cui
Journal:  Biomark Res       Date:  2022-05-03

Review 5.  Autophagy and ncRNAs: Dangerous Liaisons in the Crosstalk between the Tumor and Its Microenvironment.

Authors:  Gracie Wee Ling Eng; Yilong Zheng; Dominic Wei Ting Yap; Andrea York Tiang Teo; Jit Kong Cheong
Journal:  Cancers (Basel)       Date:  2021-12-21       Impact factor: 6.639

Review 6.  Multiple Myeloma Cell-Derived Exosomes: Implications on Tumorigenesis, Diagnosis, Prognosis and Therapeutic Strategies.

Authors:  Alessandro Allegra; Mario Di Gioacchino; Alessandro Tonacci; Claudia Petrarca; Caterina Musolino; Sebastiano Gangemi
Journal:  Cells       Date:  2021-10-24       Impact factor: 6.600

7.  Revealing the Mechanism of Friedelin in the Treatment of Ulcerative Colitis Based on Network Pharmacology and Experimental Verification.

Authors:  Bei Shi; Suxian Liu; Aoshuang Huang; Mengyun Zhou; Boyun Sun; Hui Cao; Jingyi Shan; Bo Sun; Jiang Lin
Journal:  Evid Based Complement Alternat Med       Date:  2021-11-02       Impact factor: 2.629

Review 8.  Exosomal RNAs: Novel Potential Biomarkers for Diseases-A Review.

Authors:  Jian Wang; Bing-Lin Yue; Yong-Zhen Huang; Xian-Yong Lan; Wu-Jun Liu; Hong Chen
Journal:  Int J Mol Sci       Date:  2022-02-23       Impact factor: 5.923

Review 9.  Exosome-Mediated Therapeutic Strategies for Management of Solid and Hematological Malignancies.

Authors:  Alessandro Allegra; Claudia Petrarca; Mario Di Gioacchino; Marco Casciaro; Caterina Musolino; Sebastiano Gangemi
Journal:  Cells       Date:  2022-03-27       Impact factor: 6.600

Review 10.  Circular RNA as a Novel Biomarker for Diagnosis and Prognosis and Potential Therapeutic Targets in Multiple Myeloma.

Authors:  Alessandro Allegra; Nicola Cicero; Alessandro Tonacci; Caterina Musolino; Sebastiano Gangemi
Journal:  Cancers (Basel)       Date:  2022-03-27       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.